Recent progress on elucidating the molecular mechanism of plasmid-mediated colistin resistance and drug design
Related Experiment Video
Updated: Jan 1, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
1Department of Thoracic Surgery, Hubei Cancer Hospital, Wuhan, 430079, China.
Abstract:
Antibiotic resistance is a growing global challenge to public health. Polymyxin is considered to be the last-resort antibiotic against most gram-negative bacteria. Recently, discoveries of a plasmid-mediated, transferable mobilized polymyxin resistance gene (mcr-1) in many countries have heralded the increased threat of the imminent emergence of pan-drug-resistant super bacteria. MCR-1 is an inner membrane protein that enables bacteria to develop resistance to polymyxin by transferring phosphoethanolamine to lipid A. However, the mechanism associated with polymyxin resistance has yet to be elucidated, and few drugs exist to address this issue. Here, we review our current understanding regarding MCR-1 and small molecule inhibitors to provide a detailed enzymatic mechanism of MCR-1 and the associated implications for drug design.
Insights
The mobilized colistin resistance gene (mcr-1) confers resistance to last-resort antibiotics. Understanding its enzymatic mechanism is crucial for developing new drugs against pan-drug-resistant bacteria.
Area of Science:
- Microbiology
- Drug Resistance
- Biochemistry
Background:
- Antibiotic resistance poses a significant global health threat.
- Polymyxins are critical last-resort antibiotics for treating infections caused by gram-negative bacteria.
- The emergence of plasmid-mediated transferable polymyxin resistance genes, such as mcr-1, is a growing concern, potentially leading to pan-drug-resistant bacteria.
Purpose of the Study:
- To review current knowledge on the mobilized colistin resistance gene (mcr-1).
- To elucidate the detailed enzymatic mechanism of MCR-1.
- To explore implications for designing novel small molecule inhibitors against polymyxin resistance.
Main Methods:
- Literature review of studies on mcr-1 and polymyxin resistance.
- Analysis of the biochemical function of MCR-1 as a phosphoethanolamine transferase.
- Examination of structure-activity relationships for potential drug design.
Main Results:
- MCR-1 confers resistance by modifying lipid A through phosphoethanolamine transfer.
- The enzymatic mechanism involves specific interactions within the bacterial inner membrane.
- Limited understanding of the precise mechanism hinders the development of effective inhibitors.
Conclusions:
- MCR-1 represents a critical mechanism for polymyxin resistance in gram-negative bacteria.
- Elucidating the enzymatic pathway of MCR-1 is essential for combating pan-drug resistance.
- Targeting MCR-1 with small molecule inhibitors offers a promising strategy for future drug development.
Related Concept Videos
Development of Antibiotic Resistance
Antibiotic Selection
Gene Regulation in Microbial Communities: Quorum Sensing
Plasmids
Coordination of Gene Expression Processes in Bacteria
Combined Effects of Drugs: Synergism
Such synergistic combinations...

